SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : idb/to..idbe/nas long term growth -- Ignore unavailable to you. Want to Upgrade?


To: keokalani'nui who wrote (80)7/12/2005 9:16:31 AM
From: tom pope  Respond to of 85
 
09:00 ET ID Biomedical flu vaccine Fluviral granted Fast Track status by FDA (IDBE) 17.60 :Co expects that with the U.S. regulatory approval of its injectable flu vaccine and a successful pre-approval inspection of its facilities, it will be able to produce approx 20-25 mln doses of influenza vaccine for the U.S. market in 2006, and approx 40 mln doses in 2007.